The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Vishwanauth Persaud

doi:10.47363/jhsr/2025(4)130

September 1, 2025Journal of Health Statistics Reports

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

View at Publisher

Ask AI

Bookmark

Share

Key Points

The introduction of a Uniform National Formulary could significantly reduce drug affordability disparities in the U.S.
Cost analyses of cystic fibrosis treatment with Trikafta highlight how inequitable access affects patient outcomes.
Observational assessment of current healthcare policies reveals critical barriers to medication access for affected populations.
Improving access to essential medications through a Uniform National Formulary may lead to more equitable healthcare outcomes.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Analysis shows a Uniform National Formulary may improve medication access in the U.S., suggesting equity in health policy is crucial.

Abstract

Background: Access to essential medications is critical for an equitable healthcare system, yet the absence of a Uniform National Formulary (UNF) in the U.S. has led to disparities in drug affordability and access.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vishwanauth Persaud (2025) studied this question.

synapsesocial.com/papers/68bb49bc6d6d5674bccff6d3 https://doi.org/10.47363/jhsr/2025(4)130

View at Publisher

Ask AI

Bookmark

Share

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading